Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 121–135 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-539 Alpha Thalassemia Gene Analysis (HBA1 & HBA2) Test This test identifies deletions and point mutations within the HBA1 and HBA2 genes, which are responsible for producing alpha-globin chains of hemoglobin.	EDTA Whole Blood	14–21 calendar days	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Deletions in HBA1 gene", "Deletions in HBA2 gene", "Point mutations in HBA1 gene", "Point mutations in HBA2 gene"] Parameters [] Preparation ["No fasting is required.", "Inform phlebotomist of any recent transfusions or medications.", "Share full medication list with the phlebotomist prior to collection."] Indications ["Diagnosis of alpha thalassemia trait", "Diagnosis of alpha thalassemia carrier status", "Diagnosis of hemoglobin H disease", "Pre-marital screening", "Prenatal diagnosis planning", "Evaluation of unexplained microcytic anemia"] Measurement technique Confirm with laboratory Codes LOINC: 48768-6 ICD-10: D56.0 Clinical summary This test identifies deletions and point mutations within the HBA1 and HBA2 genes, which are responsible for producing alpha-globin chains of hemoglobin.
TEST-526 Alpha Thalassemia HBA1–HBA2 Deletion‑Duplication Analysis Test This diagnostic test evaluates for large genetic rearrangements (deletions and duplications) within the HBA1 and HBA2 genes, which are the primary cause of alpha-thalassemia.	Whole blood (EDTA)	2–3 Weeks	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Deletions in HBA1 gene", "Duplications in HBA1 gene", "Deletions in HBA2 gene", "Duplications in HBA2 gene"] Parameters [] Preparation ["Do not discontinue prescribed medication without consulting your physician.", "Results should be interpreted alongside complete blood count and hemoglobin electrophoresis."] Indications ["Suspected alpha-thalassemia", "Family screening for alpha-thalassemia", "Inconclusive results from other tests", "Pre-conception carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 42513-7 ICD-10: D56.0 Clinical summary This diagnostic test evaluates for large genetic rearrangements (deletions and duplications) within the HBA1 and HBA2 genes, which are the primary cause of alpha-thalassemia.
TEST-1859 Alpha Thalassemia Mutation Screening (3 Common Mutations) Test This test identifies the presence of three common alpha-globin gene mutations associated with alpha-thalassemia carrier status and disease.	Peripheral Whole Blood	7–8 working days	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Presence of specific HBA1/HBA2 gene mutations", "Alpha-globin gene variant genotyping"] Parameters [] Preparation ["No fasting required", "Inform healthcare provider about medications/supplements"] Indications ["Carrier screening", "Diagnosis of alpha-thalassemia", "Pre-conception counselling", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 49273-9 ICD-10: D56.0 Clinical summary This test identifies the presence of three common alpha-globin gene mutations associated with alpha-thalassemia carrier status and disease.
TEST-6077 Alpha-2-Macroglobulin Deficiency Genetic Test (A2M NGS) This test identifies genetic variants in the A2M gene associated with alpha-2-macroglobulin deficiency.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["A2M gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No dietary restrictions", "No medication adjustments"] Indications ["Suspected alpha-2-macroglobulin deficiency", "Family history of alpha-2-macroglobulin deficiency", "Evaluation of metabolic disorders", "Evaluation of pulmonary conditions"] Measurement technique Confirm with laboratory Codes LOINC: 91854-7 ICD-10: E88.09 Clinical summary This test identifies genetic variants in the A2M gene associated with alpha-2-macroglobulin deficiency.
TEST-6110 ALPL Gene Hypophosphatasia (Adult) Genetic Test This genetic test identifies mutations within the ALPL gene, which are responsible for causing adult hypophosphatasia.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ALPL gene mutations", "Deletions/Duplications in ALPL gene"] Parameters [] Preparation ["No fasting required"] Indications ["Suspected adult hypophosphatasia", "Low alkaline phosphatase levels with clinical symptoms", "Family history of hypophosphatasia"] Measurement technique Confirm with laboratory Codes LOINC: 81239-4 ICD-10: E83.30, Z15.09 Clinical summary This genetic test identifies mutations within the ALPL gene, which are responsible for causing adult hypophosphatasia.
TEST-6161 ALPL Gene Hypophosphatasia (Childhood-Onset) Genetic Test This genetic test identifies pathogenic variants in the ALPL gene associated with childhood-onset hypophosphatasia.	Peripheral blood (3–5 mL EDTA) or FTA card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ALPL gene sequence", "Copy number variations in ALPL gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of recent blood transfusions or active infections"] Indications ["Suspected childhood-onset hypophosphatasia", "Family history of hypophosphatasia", "Low serum alkaline phosphatase with skeletal abnormalities"] Measurement technique Confirm with laboratory Codes LOINC: 83238-2 ICD-10: E83.39 Clinical summary This genetic test identifies pathogenic variants in the ALPL gene associated with childhood-onset hypophosphatasia.
TEST-5965 ALPL Gene Odontohypophosphatasia Genetic Test This test analyzes the entire ALPL gene to identify mutations causing Odontohypophosphatasia.	Whole blood, FTA card, or extracted genomic DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ALPL gene sequence", "Single nucleotide variants", "Small insertions and deletions", "Copy number alterations"] Parameters [] Preparation [] Indications ["Suspected Odontohypophosphatasia", "Differential diagnosis of metabolic bone disorders", "Carrier screening for at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 94831-8 ICD-10: E83.39 Clinical summary This test analyzes the entire ALPL gene to identify mutations causing Odontohypophosphatasia.
TEST-5617 ALS2 Gene Spastic Paralysis, Infantile Onset Ascending NGS Test This test identifies pathogenic variants in the ALS2 gene associated with infantile-onset ascending spastic paralysis.	Blood (Whole Blood EDTA), Dried Blood Spot (DBS), Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ALS2 gene", "Single nucleotide variants", "Small insertions", "Small deletions"] Parameters [{"name": "Target Region Coverage", "reference_range": "Full gene (all exons, intron boundaries)"}, {"name": "Variant Detection Sensitivity", "reference_range": "99.9%"}] Preparation ["No specific fasting required.", "Inform the lab of any relevant family history."] Indications ["Suspected diagnosis of ALS2-related spastic paralysis", "Family history of hereditary spastic paraplegia"] Measurement technique Confirm with laboratory Codes LOINC: 81261-5 ICD-10: G11.4 Clinical summary This test identifies pathogenic variants in the ALS2 gene associated with infantile-onset ascending spastic paralysis.
TEST-2826 ALX3 Gene Frontonasal Dysplasia Type 1 Genetic Test This genetic test evaluates the ALX3 gene for pathogenic variants associated with Type 1 frontonasal dysplasia.	Whole blood (EDTA), extracted DNA, or FTA card blood spot	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ALX3 gene pathogenic variants", "Copy number variations (CNVs) in ALX3"] Parameters [] Preparation [] Indications ["Suspected frontonasal dysplasia", "Family history of frontonasal dysplasia", "Recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q75.8 Clinical summary This genetic test evaluates the ALX3 gene for pathogenic variants associated with Type 1 frontonasal dysplasia.
TEST-5504 ALX4 Gene Parietal Foramina Type 2 Genetic Test This genetic test evaluates the ALX4 gene for pathogenic mutations associated with parietal foramina type 2 (PFM2).	Whole blood (EDTA), extracted genomic DNA, or dried blood spot on FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ALX4 gene coding region", "ALX4 gene splice sites"] Parameters [] Preparation [] Indications ["Definitive diagnosis of PFM2", "Family screening", "Reproductive risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q75.8 Clinical summary This genetic test evaluates the ALX4 gene for pathogenic mutations associated with parietal foramina type 2 (PFM2).
TEST-6035 AMACR Gene (Bile Acid Synthesis Defect Type 4, Congenital) Genetic Test This test analyzes the AMACR gene for pathogenic variants associated with congenital bile acid synthesis defect type 4.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AMACR gene", "Single nucleotide variants", "Indels", "Copy number changes"] Parameters [] Preparation [] Indications ["Suspected congenital bile acid synthesis defect type 4", "Family screening", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 47956-1 ICD-10: E71.5 Clinical summary This test analyzes the AMACR gene for pathogenic variants associated with congenital bile acid synthesis defect type 4.
TEST-6082 AMACR Gene Sequencing (Alpha-Methylacyl-CoA Racemase Deficiency) Test This test analyzes the AMACR gene for pathogenic variants associated with Alpha-Methylacyl-CoA Racemase Deficiency.	Blood (2–5 ml EDTA), Extracted DNA (1–2 µg), or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AMACR gene", "Deletion/duplication analysis of the AMACR gene"] Parameters [] Preparation [] Indications ["Diagnosis of Alpha-Methylacyl-CoA Racemase Deficiency", "Evaluation of adult-onset neuropathy", "Investigation of bile acid synthesis defects"] Measurement technique Confirm with laboratory Codes LOINC: 94293-0 ICD-10: E71.6 Clinical summary This test analyzes the AMACR gene for pathogenic variants associated with Alpha-Methylacyl-CoA Racemase Deficiency.
TEST-5453 AMELX Gene Sequencing Test (Amelogenesis Imperfecta, Type 1E) This test evaluates the AMELX gene for mutations associated with X-linked Amelogenesis Imperfecta Type 1E.	Whole Blood (EDTA), Extracted DNA, or One Drop Blood on FTA Card	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants in AMELX gene", "Small indels in AMELX gene", "Copy Number Variations (CNV) in AMELX gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Clinical signs of Amelogenesis Imperfecta", "Family history suggestive of X-linked inheritance"] Measurement technique Confirm with laboratory Codes LOINC: 81353-1 ICD-10: K00.4 Clinical summary This test evaluates the AMELX gene for mutations associated with X-linked Amelogenesis Imperfecta Type 1E.
TEST-4683 AMER1 Gene Osteopathia Striata with Cranial Sclerosis Genetic Test This genetic test evaluates the AMER1 gene for pathogenic variants associated with Osteopathia Striata with Cranial Sclerosis.	Whole Blood (EDTA), Extracted DNA, FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AMER1 gene"] Parameters [] Preparation ["Complete a comprehensive clinical history form", "Attend a pre-test genetic counselling session"] Indications ["Individuals with clinical signs of osteopathia striata with cranial sclerosis", "At-risk family members", "Prenatal diagnosis in families with an identified AMER1 variant", "Asymptomatic carriers", "Differential diagnosis for sclerosing bone disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94531-1 ICD-10: Q78.8 Clinical summary This genetic test evaluates the AMER1 gene for pathogenic variants associated with Osteopathia Striata with Cranial Sclerosis.
TEST-3425 AMH Gene Persistent Müllerian Duct Syndrome Type 1 Genetic Test This test detects pathogenic variants in the AMH gene associated with Persistent Müllerian Duct Syndrome Type 1.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AMH gene", "Presence of mutations causing PMDS Type 1"] Parameters [] Preparation ["Do not alter or discontinue prescribed medications without consulting your treating physician."] Indications ["Suspected Persistent Müllerian Duct Syndrome Type 1", "Individuals with ambiguous genitalia or related clinical findings", "Family history of PMDS"] Measurement technique Confirm with laboratory Codes LOINC: 81653-4 ICD-10: Q55.8 Clinical summary This test detects pathogenic variants in the AMH gene associated with Persistent Müllerian Duct Syndrome Type 1.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories